Curis Inc (CRIS): Cash & Equivalents
$5.06M
As of 2025-12-31
$5.07M
As of 2026-06-30
-36.4%
3-year compound annual growth
-47.7%
5-year compound annual growth
-17.1%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.06M | -74.7% | 2026-03-24, Balance as of period end |
| 2024-12-31 | $20.00M | -25.1% | 2026-03-24, Balance as of period end |
| 2023-12-31 | $26.68M | +35.7% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $19.66M | -50.9% | 2024-02-08, Balance as of period end |
| 2021-12-31 | $40.01M | -69.1% | 2023-03-13, Balance as of period end |
| 2020-12-31 | $129.61M | +740.0% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $15.43M | -34.7% | 2021-03-16, Balance as of period end |
| 2018-12-31 | $23.64M | -38.3% | 2020-03-19, Balance as of period end |
| 2017-12-31 | $38.29M | +47.0% | 2019-03-26, Balance as of period end |
| 2016-12-31 | $26.04M | -21.3% | 2018-03-08, Balance as of period end |
| 2015-12-31 | $33.09M | +327.1% | 2018-03-08, Balance as of period end |
| 2014-12-31 | $7.75M | -19.2% | 2017-03-09, Balance as of period end |
| 2013-12-31 | $9.59M | -24.8% | 2016-02-29, Balance as of period end |
| 2012-12-31 | $12.75M | -15.7% | 2015-02-24, Balance as of period end |
| 2011-12-31 | $15.12M | +93.2% | 2014-03-13, Balance as of period end |
| 2010-12-31 | $7.83M | +7.6% | 2013-03-13, Balance as of period end |
| 2009-12-31 | $7.28M | n/a | 2012-02-29, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Curis Inc (CRIS) | 2025-12-31 | $5.06M | -74.7% |
| Taysha Gene Therapies, Inc. (TSHA) | 2025-12-31 | $319.77M | +130.0% |
| Alpha Cognition Inc. (ACOG) | 2025-12-31 | $66.05M | +36.0% |
| TScan Therapeutics, Inc. (TCRX) | 2025-12-31 | $152.41M | -14.7% |
| Caribou Biosciences, Inc. (CRBU) | 2025-12-31 | $12.36M | -24.1% |
| Fate Therapeutics Inc (FATE) | 2025-12-31 | $46.63M | +29.3% |
| Lineage Cell Therapeutics, Inc. (LCTX) | 2025-12-31 | $40.79M | -10.9% |
| Relay Therapeutics, Inc. (RLAY) | 2025-12-31 | $84.02M | -32.4% |
| DBV Technologies S.A. (DBVT) | 2025-12-31 | $194.17M | +498.2% |
Compare CRIS, TSHA, ACOG, TCRX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗